Log In
Print this Print this

mAb against SOD1

  Manage Alerts
Collapse Summary General Information
Company ProMIS Neurosciences Inc.
Description mAb against misfolded superoxide dismutase (SOD1)
Molecular Target Superoxide dismutase 1 (SOD1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today